How Gilead Priced Its $20 Billion BlockbusterBy
Gilead documents provide a rare glimpse into price decisions
`We have to get most of the way there in the initial pricing'
From the start, the miracle drug was expected to carry a high price tag: $36,000 to treat each patient.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.